Objectives: To quantify the extent to which the participantprovider interaction influences the response to sham treatment following exercised-induced acute musculoskeletal pain.
T he placebo effect is a widespread phenomenon in clinical practice and research. Beecher first reported that the placebo effect is prevalent in 35% of clinical cases and therefore, should be accounted for in clinical trials. 1 Placebo effect has since been included into the "gold standard" for scientific studies which is now known as the double-blind randomized controlled trial. The theory behind the placebo effect was to include a treatment group that did not receive an active treatment or therapy, which allowed scientists the ability to judge the true effect of the active intervention being studied. The magnitude of the placebo effect can be observed in many allied health care disciplines including nursing, physical therapy, and athletic training. In some cases, the placebo effect is seen to override pharmacological effects. Levine et al 2 suggested that the placebo effect can be just as strong as a hidden injection of morphine. Schachter and Singer 3 were able to demonstrate that the effects of epinephrine were reduced when participants were misinformed as to the action of the drug. Understanding the mechanism of the placebo response is essential for all medical practitioners, particularly those dealing with patients with conditions that have reported to be most influenced by the placebo effect such as chronic pain, depression, and impaired motor function. 4 However, there seems to be a current lack of literature on the placebo response and its effect on acute musculoskeletal pain.
The management of musculoskeletal pain and dysfunction after acute injury varies widely among health care providers. Ekman and Koman 4 suggest that acute musculoskeletal pain is often undertreated even though practitioners should be adept at addressing acute pain associated with a variety of musculoskeletal conditions, including ankle sprains, back pain, and other outpatient procedures. Unfortunately, inadequately treated acute pain can result in sensitization of the peripheral and central nervous system leading to the development of chronic pain. 5, 6 Treatment of acute pain may include the use of therapeutic modalities such as cryotherapy, electrotherapy, massage, and phototherapy. Much attention and scientific inquiry have been directed toward the benefits of these therapeutic modalities, whereas very little attention has been given to the value of the participant-provider interaction as a stand-alone therapeutic "modality" for pain relief and recovery. 7 The rationale for providing positive expectations of pain relief and recovery by the provider in conjunction with a therapeutic treatment is rooted in the notion that such information can lead to a better clinical outcomes. 8 The psychosocial influence of increasing positive expectations can cause a lessening of fear, stress, and anxiety in the patient, 9 as well as an increase in self-esteem and improved coping. 10 Stress and anxiety are known entities that may adversely affect the body and increase the patient's focus on symptoms. 9 Therefore, reduction of stress, fear, and anxiety may subsequently reduce the severity of physical symptoms and impairment and facilitate recovery.
Placebo interventions have been studied using the concepts of 2 theories: expectancy 11 and conditioning. [12] [13] [14] Expectancy as a placebo intervention is related to a patient's expectation of improvement, which is directly linked to physiological reactions in the body that improve functional recovery and lessen the symptomatic response. 9, 15, 16 Finniss and Benedetti 17 reported that the use of appropriate words activate centrally located pathways for endogenous opioids or dopamine systems, in turn, decreasing pain. Conditioning relates to the patient's exposure to the provider and treatment being provided. 13 Because of these exposure(s) with the provider and treatment, the patient will associate the provider and treatment with healing and recovery. 13, 14 Klinger et al 14 suggested that the placebo effect is mediated by instruction as well as by conditioning. Expectancy is a conscious process communicated to the patient, 18 whereas conditioning is a learned response and occurs at the subconscious level. 13, 14 Kirsch 19 suggests that the effects of conditioning are mediated by expectancy, but both mechanisms when used together illicit a greater placebo response than by 1 mechanism alone. Expectancy is associated with both a greater magnitude of placebo-related hypoalgesia 8, 20, 21 and clinical outcomes in patients presenting with musculoskeletal pain. 22, 23 In contrast, Bialosky et al 24 has shown that enhanced expectations can improve a person's satisfaction with an intervention even though the clinical outcomes were not significantly different from other groups in the study. Smeets et al 25 observed similar findings on low back pain which demonstrated that higher expectations of recovery before an active therapeutic intervention (pretreatment) resulted in participants experiencing a greater perceived effect of the intervention, which reduced their low back pain. Smeets et al 25 further suggests that future studies should examine therapeutic pretreatments, specifically the inclusion of an explanation of the therapeutic effects (eg, expectancy) before a treatment. Previous research has evaluated how placebo expectancy can improve a symptomatic response. 26, 27 However, there is little research measuring the influence of the placebo effect on pain and function after musculoskeletal injury.
The primary objective of this study was to determine how an instructional set affects responses to a sham treatment following exercise-induced musculoskeletal injury. We were able to achieve this by controlling how expectations were set during the participant-provider interaction before a sham treatment. We hypothesized that individuals that were part of the positive expectancy (PE) interaction would have greater symptomatic response and functional recovery.
MATERIALS AND METHODS
The Institutional Review Board of the University of Florida approved this study. A total of 40 (29 females and 11 males) individuals volunteered to participate in the study (Table 1) . Volunteers responded to posted advertisements via e-mail, and a research assistant followed-up the e-mails with a series of questions to screen the individual for eligibility requirements. Volunteers were excluded from participation if they reported involvement in regular (2 to 3 times a week) resistance training exercise (eg, weight lifting) or had any injury to the upper extremity (shoulder/arm/ wrist/hand) in the past 6 months that would prevent them from performing the resistance exercise protocol. Volunteers were also excluded if they reported taking nutritional supplements or anti-inflammatory medication on a daily basis.
We used a double-blind, randomized, 2-arm experimental design to investigate the effects of controlling expectation in combination with a placebo intervention on symptomatic response and functional recovery following exercise-induced arm pain and dysfunction. Participants completed a 5-day trial that involved 3 laboratory visits, including the baseline assessment, resistance exercise protocol, placebo administration coupled with sham therapeutic treatment and 2 follow-up appointments ( Table 2) .
During the first visit (day 1) participants read and signed an informed consent and completed a brief health screen (height, weight, blood pressure). Participants were then randomly assigned to a PE group (n = 20) or a no expectancy (NE) group (n = 20). Participants completed a series of preexercise measurements before completing a high-intensity resistance exercise protocol. The resistance exercise protocol was designed to induce muscle damage characterized by a delayed onset of muscle soreness, stiffness, and functional impairment. A sham treatment using a therapeutic laser was administered to both groups following the exercise protocol. The provider gave participants in the PE group the following information verbally before receiving the sham treatment on day 1 (baseline) and day 3 (48-hour postinjury): "Hello, I have extensive experience with using the therapeutic laser and you can expect the treatment to significantly decrease your pain level and speed your recovery." The provider also answered any questions the participant had concerning the treatment. The provider gave participants in the NE group the following information verbally before receiving the sham treatment: "You will undergo a therapeutic treatment for your impairment and since this is a scientific study I will not be able to speak with you during the treatment." In each condition, the same provider administered the placebo intervention and sham therapy to participants.
After the intervention we administered our expectancy manipulation check, which was assessed by having all participants use a 100 mm visual analog scale (VAS) to predict how much pain they expected to experience in their biceps muscle on their ensuing follow-up visit. This was completed at the end of day 1 to predict pain for day 3, and again at the completion of day 3 to predict pain for day 5. Follow-up assessments were performed on day 3 (48-hour postinjury) and day 5 (96-hour postinjury). Preinjury and postinjury measures included self-report rating of muscle pain using a VAS, elbow range of motion (ROM), biceps muscle strength, and a self-report questionnaire for symptoms and disability of the upper extremity. Participants were unaware that the phototherapy (laser) treatment was a sham.
Blinding
The provider administering the placebo intervention and sham laser treatment was separate from the individual who completed the clinical measures. The participants and examiner were blinded to group assignment. The provider was aware of group assignment, but was blinded to outcome measures.
Informed Consent and Debriefing
All participants were required to sign the inform consent; however, the consent disclosure omitted or altered certain descriptors of the study's scientific purpose and design. For the purpose of consent, the title of the study was altered to read "The effects of laser therapy on exerciseinduced muscle pain and soreness." In the consent document, participants were informed that the trial was a study of the effectiveness of laser therapy for exercise-induced muscle soreness. Therefore, they were unaware of the study's primary objective. The omissions and alterations to the nature or purpose of the study were necessary to prevent the participants from knowing the actual objective of the study. Knowledge of the true objective would likely have negatively affected the outcomes of the study. The deceptive practices posed no harm to the participants.
After completing the project, each participant was debriefed by the examiner and given the opportunity to rescind their initial consent once the true purpose of the experiment was revealed. A debriefing form was then read and signed by the participant indicating whether or not they allowed their data to be used. No participants withdrew from the study and all of the participants consented to the use of their data after the debriefing was completed.
Fatigue Protocol
Muscle damage was induced using high-intensity resistance exercise. An isokinetic testing and exercise device (Kin-Com 125 AP, Isokinetic International, Chattanooga, TN) provided resistance for the exercising muscle group (biceps brachii). Before starting the exercise protocol, each participant performed a series of stretching exercises involving all of the major muscle groups of the upper extremity. Participants were then seated in the isokinetic testing device with their dominant arm secured at their side in 90-degree elbow flexion. The participants' maximum voluntary isometric contraction (MVIC) was measured before completion of the exercise protocol consisting of repeated concentric and eccentric (lengthening) contractions of the biceps brachii. The angular velocity was set at 45 degrees per second for concentric actions and 60 degrees per second for eccentric actions. Each participant was instructed to perform the repetitions "as hard as they can," while the examiner provided verbal encouragement throughout the exercise protocol. Participants completed 3 sets of 20 repetitions separated by 1 minute of recovery followed-up with a postexercise MVIC measurement. The protocol was considered complete if the follow-up MVIC was <50% of the participant's initial MVIC. If the postexercise MVIC was higher than 50%, additional sets of 20 repetitions were completed until the aforementioned criteria was met.
Sham Treatment
A sham laser treatment was administered to the affected muscle following exercise/placebo intervention using a "dummy" laser diode. The sham laser treatment was performed in identical manner to an active treatment, except that the output power of the laser was disabled. The participant was then instructed to lay supine and was given proper eye protection. The examiner then proceeded to mimic a true laser therapy treatment by scanning the diode over the top of the affected area (biceps brachii). Treatment time was 5 minutes.
Measures

Self-reported Pain
A VAS was used to rate the amount of bicep's muscle pain. The VAS contains a line from 0 to 10 cm with 0 representing "no pain" and 10 representing "extreme pain." Participants were asked to draw a single dash through the line at the location that most ideally represents their level of pain.
ROM
Relaxed elbow angle (RANG) was used to quantify limitations in elbow ROM as a result of the induced injury. The RANG was measured using a standard 2-arm plastic goniometer by having the participants stand with their dominant arm relaxed in a supinated position at their side. The RANG was measured in degrees.
Strength
Strength of the biceps brachii muscle was assessed using a maximal MVIC. MVIC is the maximum voluntary force produced during an isometric muscle contraction. Participants were seated in the Kin-Com with their 
Self-reported Upper Extremity Disability
The QuickDASH (Disability of the Arm, Shoulder, and Hand) questionnaire was used to assess self-reported symptoms and disability. 28 The QuickDASH focuses on the participant's ability to use the affected arm during activities of daily living. Participants rated their symptoms and ability to perform specific tasks using a 5-point hierarchical Likert scale. Scores were obtained by summing circled responses, dividing the total by the number of items answered, subtracting 1, and then multiplying that figure by 25. A score of 0 represents no symptoms or disability, whereas higher scores represent a higher level of symptoms and disability, with 100 being the highest possible score. A minimum of 10 questions must be answered to score the QuickDASH.
Statistical Analysis
All statistical procedures were performed with PASW Statistics 18.0 statistical package (IBM SPSS Inc., Armonk, NY). A 2 (condition) by 3 (time) analysis of variance with repeated measures on the second factor was performed for all outcome measures to identify any significant differences between groups over time. Tukey post hoc testing was administered in the presence of an interaction effect. Statistical significance was set at P < 0.05. Bivariate Pearson correlation coefficients were performed to assess the level of associations between each dependent variable.
RESULTS
Expectation Manipulation Check
The PE group did have lower VAS scores than the NE group for expected pain for day 3 and day 5 but they did not achieve statistical significance at the 0.05 level. Further investigation by calculating effect sizes demonstrated that changes in expectation were in the appropriate direction and corresponded with a moderate change. Expectation differences for day 3 for the PE group was 46. 
Self-reported Pain
There was a significant between-group difference observed in self-reported pain (F 1,38 = 4.5; P = 0.041; (Fig. 1) .
ROM
There were no between-group mean differences (P > 0. 05 (Fig. 2) .
Strength
Between-group differences for strength were not different (P > 0.05) throughout the length of the study ( (Fig. 3) .
Self-reported Disability
There were no between-group mean differences (P > 0.05) observed for QuickDASH scores at baseline (PE group 4. (Fig. 4) .
Bivariate Correlations
We observed moderate to large negative correlations (r = À0.30 to r = À0.60) between strength (MVIC) and disability (QuickDash) throughout postinjury recovery for both groups (Table 3) . These significant correlations indicated that as upper extremity disability diminished over time of recovery strength levels were improving. All other bivariate correlations were below r = 0.30. Mean VAS scores-compares mean VAS scores of expectancy versus nonexpectancy groups on day 1, day 3, and day 5, *significant between-group difference observed on day 3. NE indicates no expectancy; PE; positive expectancy; VAS, visual analog scale.
DISCUSSION
Our results indicated that expectancy reduces the symptomatic response after acute musculoskeletal injury, but not functional and disability outcomes. Our main finding was that the group receiving positive expectation priming with a sham laser treatment perceived less muscular pain 48 hours after injury when compared with the group that received no expectations. This is potentially clinically important because it demonstrates that positive expectations, when delivered before even an inert therapeutic modality treatment, can improve a participant's symptomatic recovery. This finding is consistent with other studies that have investigated expectancy for hypoalgesia with chronic pain and indicates that the brain may have a similar response to mediate acute musculoskeletal pain. [29] [30] [31] [32] [33] [34] A strength of this study was the injury model, which allowed us to examine expectancy from the controlled onset of an acute musculoskeletal injury until recovery as both groups returned close to baseline levels by day 5.
We can partially explain this response by reviewing recent studies that examine brain imaging in association with expectancies. The rostral anterior cingulate cortex (rACC) is known to be a region of the brain that has an abundance of opioid receptors and has an important region in opioid analgesia and other forms of pain modulation. 30 Petrovic et al 30 used positron emission tomography to scan the brain and observed that the rACC became much more active with placebo responders compared with nonresponders. Petrovic et al 30 also was able to show that the rACC became more active while modulating pain. Bingel et al 31 and Kong et al 33 have noted that giving participants expectancies before applying a sham intervention activates the rACC on an functional magnetic resonance imaging, in contrast to a "pain only" condition, where the rACC was not involved. These studies corroborate the findings of Wager et al 32 who examined areas of the brain during the anticipatory period before a pain stimulus was applied. Results indicated a higher brain activity in the orbitofrontal cortex, dorsolateral prefrontal cortex, rACC, and midbrain FIGURE 2. Mean RANG scores-compares mean RANG scores of expectancy versus nonexpectancy groups on day 1, day 3, and day 5, no significant differences observed. NE indicates no expectancy; PE; positive expectancy; RANG, relaxed elbow angle. 
periaqueductal gray. This elevated brain activity in accordance with pain theories suggest that the brainstem opioid system may be under cognitive control from a higher cortical region, which would include the rACC. 30 Kong et al 33 and Bingel et al 31 studies supported by the findings of de la Fuente-Fernandez et al, 35 which suggests that opioids are involved in expectancy-enhanced therapeutic intervention. Our results support the theory that dopamine release can modulate pain, as our participants were able to decrease pain without any significant improvement in function at the site of the injury. These results are indicative that symptomatic relief improved independently from healing and functional recovery of the injured area. This could be useful clinically as it shows that expectations alone can differentially influence pain and symptom trajectories following acute musculoskeletal injuries.
The results of our functional and disability outcome measurements (MVIC, RANG, and the QuickDASH) did not show significant improvements in recovery following musculoskeletal injury. This agrees with the previously mentioned theory, that the hypoanalgesic response is modulated by the brain, thus it may not have a direct effect on functional recovery at the site of the injury. [30] [31] [32] [33] McCracken 36 showed that there was a low correlation between acceptance and pain intensity; which indicates that acceptance is not simply a function of having low levels of pain, instead it showed that acceptance of pain predicted better adjustment on all other measures of patient function. This could be a reason why function was not altered between groups, as both groups could have possibly accepted the pain and were able to continue with activities of daily living. Personal experience by the participants with exercise-induced muscular injury may also have influenced function.
Previous studies have shown that verbal suggestions similar to the one we used in our study can augment expectations. 21, 37, 38 However, a notable limitation of this study is that we did not see a clear difference in expectations between the groups. The magnitude and direction of the expectation changes suggests a favorable response to the positive expectation instructional set, but statistical significance was not achieved. This could be because we lacked power to see differences in expectation, even though differences were noted in one of the primary outcome measures. Another reason for lack of clear differences in expectation could be because the positive expectation set was only done once before treatment-a larger change could have resulted with additional priming. Furthermore, these were healthy individuals and it may be difficult to greatly change expectations for individuals not seeking health care for pain due to expectations already being fairly positive (eg, ceiling effect). For example, as briefly mentioned while discussing the functional measurements, exercise-induced muscular injury is a common injury associated with different types of activities, such as eccentric exercise, performing new exercises, and resistance training. 39 We postulate that if our participants have had a previous experience with exercise-induced muscular injury that they may have already developed positive expectations associated with the healing process, knowing that the pain associated with this injury typically self-resolves over the course of 5 to 10 days. 39 There are some other limitations to consider with this study. There may be a different placebo response to positive expectations between our experimental injury model and a true acute musculoskeletal injury like a ligament sprain or soft tissue contusion. This study used experimental pain, which we accomplished by using the resistance exercise protocol to induce microtrauma to the biceps brachii muscle. The purpose for using this model is that it allows for treatment at the most acute phase of an injury, which is immediately after the high-intensity exercise. Musculoskeletal injury typically elicits pain and decreased function. We did not include a true control group in this study, which did not allow us to report on any between-group differences compared with a "no treatment" condition. However, because the purpose our study was to examine the influence of PE versus NE, we were able to account for one factor that could have attributed to improved healing.
Future studies should investigate blood biomarkers to see how expectancies elicit healing at the molecular and cellular level in acute musculoskeletal injuries. Implementing functional movement tests associated with the injured structure could give a better representation of the speed of healing. Observing these tests to see if improvement occurs after injury regardless if there is increased healing would be beneficial to see how far the effect of healing expectancies can extend. Repeating the study but administering followup testing at 24-hour intervals instead of 48-hour intervals would give us a more accurate representation of the effect of expectancy. Examining verbal expectation and the possible influence it may have on clinical and experimental pain would also be advantageous to future placebo studies. Adding in a conditioning component along with the positive expectation in a future study would be beneficial. Combining both mechanisms may yield larger pain relief or show an improvement in MVIC and ROM. By isolating expectancy from conditioning, we could also determine which placebo mechanism has the greatest impact on pain reduction. Lastly, it may also prove useful to use imaging such as functional magnetic resonance imaging to examine which regions of the brains are more active with expectancies associated with symptomatic relief before and after sham therapeutic treatment.
In conclusion, we were able to show that a positive expectation instructional set for a sham laser treatment following acute exercise-induced muscle injury provided better self-reported pain relief. However, in this sample, there was no difference in functional or disability outcomes based on expectancy. Symptomatic pain relief during recovery from an acute musculoskeletal injury may be enhanced with positive expectations alone, but additional intervention may be needed to see differential gains in strength or disability outcomes.
